Cabaletta Bio, Inc. (CABA) Revenue History
Annual and quarterly revenue from 2017 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CABA Revenue Growth
CABA Revenue Analysis (2017–2025)
As of May 8, 2026, Cabaletta Bio, Inc. (CABA) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, CABA's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including KYMR (-12.6% YoY), ARQT (+95.3% YoY), and ROIV (-56.4% YoY). Compare CABA vs KYMR →
CABA Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CABACurrent | $0 | - | - | - | |
 KYMR | $39M | -12.6% | +2.9% | -891.3% | |
 ARQT | $376M | +95.3% | - | -3.3% | |
 ROIV | $29M | -56.4% | -15.6% | -3453.3% |
CABA Historical Revenue Data (2017–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-172,241,000 | - |
| 2024 | $0 | - | $-4,813,000 | - | $-125,141,000 | - |
| 2023 | $0 | - | $-1,426,000 | - | $-74,660,000 | - |
| 2022 | $0 | - | $-3,684,000 | - | $-54,139,000 | - |
| 2021 | $0 | - | $-733,000 | - | $-46,313,000 | - |
| 2020 | $0 | - | $-354,000 | - | $-33,833,000 | - |
| 2019 | $0 | - | $-104,000 | - | $-18,683,000 | - |
| 2018 | $0 | - | $0 | - | $-6,193,000 | - |
| 2017 | $0 | - | $0 | - | $-250,000 | - |
See CABA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CABA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CABA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCABA — Frequently Asked Questions
Quick answers to the most common questions about buying CABA stock.
Is CABA's revenue growth accelerating or slowing?
CABA TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is CABA's long-term revenue growth rate?
Cabaletta Bio, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is CABA's revenue distributed by segment?
CABA reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2025 are available for download. Segment mix reveals concentration and diversification trends.